David Sunseri, Ph.D, is a pharmaceutical and contract research, development, and manufacturing executive with over 17 years’ experience.  Most recently, David was the Chief Executive Officer at PMI BioPharma Solutions, a contract research, development, and manufacturing organization.  As CEO, David applied his experience with leading development programs and developing new business opportunities to craft the overall strategy that drove growth and a successful acquisition for PMI Bio.

Prior to PMI Bio, David spent almost four years at Berg, LLC, in positions of increasing responsibility, leading all aspects of chemistry, manufacturing, and controls (CMC). Most recently, as vice president of product development, he oversaw clinical trial manufacturing, engineering operations, supply chain, and formulations. He also spent 10 years with Schering-Plough and Merck in small molecule inhalation and parenteral development, and in commercial manufacturing of inhalation and medical device products.

David received a bachelor’s degree in chemistry from the University of North Alabama and a Ph.D. in analytical chemistry, specializing in chromatography, from Florida State University under the direction of John G. Dorsey.

He serves on the University of North Alabama Foundation Board of Directors and also a member of the University of North Alabama’s College of Arts and Sciences advisory council.